ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000268392.1	Methotrexate	Breast invasive carcinoma	0.037212047	Resistant
ENSG00000268392.1	Methotrexate	Pancreatic adenocarcinoma	0.030763425	Resistant